FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nuvelle TS Phase I patches (Schering Health Care Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Elleste Solo MX 80 transdermal patches (Viatris UK Healthcare Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fematrix 80 patches (Solvay Healthcare Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 80micrograms patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 80micrograms/24hours patches 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 80micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nuvelle TS Phase I patches (Schering Health Care Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Elleste Solo MX 80 transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (PI) (Dowelhurst Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (PI) (Dowelhurst Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Norgine Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Novartis Pharmaceuticals UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Progynova TS 50 patches (Schering Health Care Ltd) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Sigma Pharmaceuticals Plc) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours patches 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Theramex HQ UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Merck Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Dermestril 50 patches (Strakan Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Norgine Pharmaceuticals Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (PI) (Waymade Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Novartis Pharmaceuticals UK Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Sigma Pharmaceuticals Plc) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (PI) (Dowelhurst Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (PI) (Waymade Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours patches 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Norgine Pharmaceuticals Ltd) 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Doncaster Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (PI) (Waymade Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours patches 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Dermestril - Septem 50 patches (Strakan Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (PI) (Dowelhurst Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (PI) (Dowelhurst Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Novartis Pharmaceuticals UK Ltd) 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (PI) (Waymade Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Novartis Pharmaceuticals UK Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (PI) (Waymade Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Theramex HQ UK Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours patches 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Merck Pharmaceuticals) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (PI) (Waymade Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Waymade Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours patches 20 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours patches 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Menorest 50 patches (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Menorest 50 patches (Novartis Pharmaceuticals UK Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Norgine Pharmaceuticals Ltd) 20 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Sigma Pharmaceuticals Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Progynova TS 50 patches (PI) (Dowelhurst Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Progynova TS 50 patches (PI) (Dowelhurst Ltd) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Merck Pharmaceuticals) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (PI) (Dowelhurst Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (PI) (Dowelhurst Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 50micrograms/24hours patches (Sigma Pharmaceuticals Plc) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Dermestril 50 patches (Strakan Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Theramex HQ UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Theramex HQ UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Theramex HQ UK Ltd) 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Theramex HQ UK Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Dermestril - Septem 50 patches (Strakan Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (PI) (Waymade Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Theramex HQ UK Ltd) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Novartis Pharmaceuticals UK Ltd) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Progynova TS 50 patches (Schering Health Care Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Waymade Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm 1.5mg patches (Baxter Healthcare Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 1mg/72hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Waymade Healthcare Plc) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours patches 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Novartis Consumer Health UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm 1.5mg patches (Baxter Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Novartis Consumer Health UK Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nitro-Dur 0.6mg/hour transdermal patches (Organon Pharma (UK) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Trintek 15 transdermal patches (Goldshield Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Minitran 15 transdermal patches (Viatris UK Healthcare Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours patches 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours patches 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nitro-Dur 0.6mg/hour transdermal patches (Organon Pharma (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Minitran 15 transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Trintek 15 transdermal patches (Goldshield Healthcare Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nuvelle TS Phase II patches (Schering Health Care Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 20micrograms/24hours patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nuvelle TS Phase II patches (Schering Health Care Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 20micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 200micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 2 patches (Boehringer Ingelheim Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 2 patches (Boehringer Ingelheim Ltd) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 2 patches (Boehringer Ingelheim Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 9 of 21 Next End

This concept is not in any reference sets

Back to Start